Mgm1, the yeast ortholog of mammalian OPA1, is a key component in mitochondrial membrane fusion and is required for maintaining mitochondrial dynamics and morphology. We showed recently that the purified short isoform of Mgm1 (s-Mgm1) possesses GTPase activity, self-assembles into low order oligomers, and interacts specifically with negatively charged phospholipids (Meglei, Mitochondrial dynamics have been implicated in neurodegenerative diseases such as dominant optic atrophy and Parkinson disease (1, 2). Mitochondrial morphology is regulated by balanced membrane fusion and fission reactions that are orchestrated by members of the highly conserved dynaminrelated protein family (3). Dynamin-related proteins are large GTPases that can self-assemble and promote membrane remodeling (4, 5). We have shown previously that the dynaminrelated protein Mgm1 has GTPase activity, self-assembles into low order oligomers, and binds to negatively charged phospholipids (6). Mgm1 exists as two isoforms in the mitochondria; l-Mgm1 2 is anchored to the IM via a transmembrane domain, and s-Mgm1 is peripherally associated with the IM and also found in the intermembrane space. s-Mgm1 results from the regulated cleavage by the mitochondrial rhomboid protease (7,8). It was shown recently that both isoforms are essential but have distinct roles in mitochondrial membrane fusion whereby only s-Mgm1 requires its GTPase activity (9). It is proposed that l-Mgm1 serves as a receptor for s-Mgm1 to mediate fusion of opposing membranes upon GTP hydrolysis. Here, we provide molecular data indicating that lipid binding of s-Mgm1 is required for proper membrane fusion. Furthermore, structural analysis of s-Mgm1 assembled onto liposomes suggests a model whereby stacked trimers of s-Mgm1 on opposing membranes would facilitate fusion.G EXPERIMENTAL PROCEDURESExpression and Purification of s-Mgm1-WT s-Mgm1 and point mutants were purified in buffer containing 500 mM NaCl and 1 mM dithiothreitol as described previously (6). For all subsequent in vitro assays presented here, purified WT s-Mgm1 and point mutants were diluted into buffers containing 170 mM NaCl and 1 mM dithiothreitol immediately prior to the assay.Liposome Preparation-A 10 mg/ml chloroform solution of lipid (Avanti Polar Lipids) was dried by rotary evaporation and vacuum pump, yielding a thin lipid film. The lipid suspension in physiological salt buffer was extruded 15 times through a 1-m polycarbonate Nucleopore TM track-etched membrane (Whatman) to generate unilamellar vesicles.Enzyme-linked Immunosorbent Assay-IM liposomes were prepared with the corresponding physiological concentrations: cardiolipin, 16%; phosphatidylethanolamine, 24%; phosphatidic acid, 2%; phosphatidylserine, 4%; phosphatidylcholine, 38%; and phosphatidylinositol, 16%. 2 g of total lipid was added to each well of a 96-well plate and allowed to coat overnight. Following 5% bovine serum albumin block, Mgm1 proteins were added at the concentrations indicated. Binding was detected using primary antibody directed against ...

Background: Dynamin proteins shape membranes by promoting membrane curvature, fission, and fusion. Results: Cryo-EM demonstrates how the dynamin-related protein Mgm1 assembles onto and tethers membranes followed by nucleotide-dependent conformational changes. Conclusion: Mgm1 may mediate mitochondrial fusion by bridging opposing membranes and undergoing structural transitions. Significance: This study provides new mechanistic details of how dynamins may function as fusion molecules.

Mitochondria are highly dynamic organelles that are important for many diverse cellular processes, such as energy metabolism, calcium buffering, and apoptosis. Mitochondrial biology and dysfunction have recently been linked to different types of cancers and neurodegenerative diseases, most notably Parkinson's disease. Thus, a better understanding of the quality control systems that maintain a healthy mitochondrial network can facilitate the development of effective treatments for these diseases. In this perspective, we will discuss recent advances on two mitochondrial quality control pathways: the UPS and mitophagy, highlight how new players may be contributing to regulate these pathways. We believe the proteases involved will be key and novel regulators of mitochondrial quality control, and this knowledge will provide insights into future studies aimed to combat neurodegenerative diseases.